Skip to main content
SpringerLink
Log in

Review of Laser Treatments for Post-Inflammatory Hyperpigmentation in Skin of Color

  • Review Article
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Post-inflammatory hyperpigmentation is an extremely common disorder of pigmentation in skin of color. It most frequently and severely affects phototypes that are rich in melanin and often has a chronic and unpredictable course. It presents significant treatment challenges and often requires a multi-factorial approach. We review the literature available for the optimal use of laser-based devices in the treatment of post-inflammatory hyperpigmentation, particularly for Fitzpatrick skin phototypes III–VI. For the treatment of post-inflammatory hyperpigmentation in skin of color, lasers remain second line to topical agents based on the variable response, cost, and risk of complications with laser use. For post-inflammatory hyperpigmentation resistant to topicals, laser devices, particularly neodymium:yttrium-aluminum-garnet and fractional photothermolysis systems, can provide adjunctive treatment in skin of color patients when appropriate parameters are used. Future studies would benefit from an objective and consistent assessment to assist with a systematic analysis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Abad-Casintahan F, Chow SKW, Goh CL, et al. Frequency and characteristics of acne-related post-inflammatory hyperpigmentation. J Dermatol. 2016;43(7):826–8. https://doi.org/10.1111/1346-8138.13263.

    Article  PubMed  Google Scholar 

  2. Raveendra L, Sidappa H, Shree S. A study of quality of life in patients with facial melanoses. Indian Dermatol Online J. 2020;11(2):154. https://doi.org/10.4103/idoj.IDOJ_209_19.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Silpa-Archa N, Kohli I, Chaowattanapanit S, Lim HW, Hamzavi I. Postinflammatory hyperpigmentation: a comprehensive overview: epidemiology, pathogenesis, clinical presentation, and noninvasive assessment technique. J Am Acad Dermatol. 2017;77(4):591–605. https://doi.org/10.1016/j.jaad.2017.01.035. (PMID: 28917451).

    Article  PubMed  Google Scholar 

  4. Park JY, Park JH, Kim SJ, et al. Two histopathological patterns of postinflammatory hyperpigmentation: epidermal and dermal. J Cutan Pathol. 2017;44(2):118–24. https://doi.org/10.1111/cup.12849.

    Article  PubMed  Google Scholar 

  5. Kaufman BP, Aman T, Alexis AF. Postinflammatory hyperpigmentation: epidemiology, clinical presentation, pathogenesis and treatment. Am J Clin Dermatol. 2018;19(4):489–503. https://doi.org/10.1007/s40257-017-0333-6. (PMID: 29222629).

    Article  PubMed  Google Scholar 

  6. Agbai O, Hamzavi I, Jagdeo J. Laser treatments for postinflammatory hyperpigmentation: a systematic review. JAMA Dermatol. 2017;153(2):199–206. https://doi.org/10.1001/jamadermatol.2016.4399. (PMID: 27973642).

    Article  PubMed  Google Scholar 

  7. Tanzi EL, Alster TS. Cutaneous laser surgery in darker skin phototypes. Cutis. 2004;73(1):21–4, 27–30 (PMID: 14964628).

  8. Passeron T, Genedy R, Salah L, Fusade T, Kositratna G, Laubach HJ, et al. Laser treatment of hyperpigmented lesions: position statement of the European Society of Laser in Dermatology. J Eur Acad Dermatol Venereol. 2019;33(6):987–1005. https://doi.org/10.1111/jdv.15497. (Epub 2019 Mar 14, PMID: 30873649).

    Article  CAS  PubMed  Google Scholar 

  9. Cho S, Park S, Kim J, Kim M, Bu T. Treatment of post-inflammatory hyperpigmentation using 1064-nm Q-switched Nd:YAG laser with low fluence: report of three cases. J Eur Acad Dermatol Venereol. 2009;23(10):1206–7. https://doi.org/10.1111/j.1468-3083.2009.03123.x.

    Article  CAS  PubMed  Google Scholar 

  10. Kim S, Cho K-H. Treatment of procedure-related postinflammatory hyperpigmentation using 1064-nm Q-switched Nd:YAG laser with low fluence in Asian patients: report of five cases: treatment of postinflammatory hyperpigmentation. J Cosmet Dermatol. 2010;9(4):302–6. https://doi.org/10.1111/j.1473-2165.2010.00527.x.

    Article  PubMed  Google Scholar 

  11. Zawar VP, Agarwal M, Vasudevan B. Treatment of postinflammatory pigmentation due to acne with Q-Switched neodymium-doped yttrium aluminum garnet in 78 Indian cases. J Cutan Aesthet Surg. 2015;8(4):222–6. https://doi.org/10.4103/0974-2077.172196.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Kim S, Cho KH. Treatment of facial postinflammatory hyperpigmentation with facial acne in Asian patients using a Q-switched neodymium-doped yttrium aluminum garnet laser. Dermatol Surg. 2010;36(9):1374–80. https://doi.org/10.1111/j.1524-4725.2010.01643.x.

    Article  CAS  PubMed  Google Scholar 

  13. Feng J, Huang L. Treatment of permanent post-inflammatory hyperpigmentation with medium-fluence medium-spot-size setting in Q-switched Nd: YAG 1064 nm laser: a novel treatment parameters setting strategy. J Cosmet Dermatol. 2021. https://doi.org/10.1111/jocd.14176. (Epub 2021 Apr 25).

    Article  PubMed  Google Scholar 

  14. Ghannam S, Al Otabi FK, Frank K, Cotofana S. Efficacy of low-fluence Nd:YAG 1064 nm laser for the treatment of post-inflammatory hyperpigmentation in the axillary area. J Drugs Dermatol. 2017;16(11):1118–23.

    PubMed  Google Scholar 

  15. Robredo IGC. Q-switched 1064 nm Nd:YAG laser in treating axillary hyperpigmentation in Filipino women with skin types IV–V. J Drugs Dermatol. 2020;19(1):66–9. https://doi.org/10.36849/JDD.2020.462.3.

    Article  CAS  PubMed  Google Scholar 

  16. Amornpetkul W, Kanokrungsee S, Kamanamool N, Udompataikul M, Rojhirunsakool S. Comparison between the use of intense pulsed light and Q-switched neodymium-doped yttrium aluminum garnet laser for the treatment of axillary hyperpigmentation. J Cosmet Dermatol. 2021;20(9):2785–93. https://doi.org/10.1111/jocd.13981.

    Article  PubMed  Google Scholar 

  17. Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med. 2004;34(5):426–38. https://doi.org/10.1002/lsm.20048. (PMID: 15216537).

    Article  PubMed  Google Scholar 

  18. Laubach HJ, Tannous Z, Anderson RR, Manstein D. Skin responses to fractional photothermolysis. Lasers Surg Med. 2006;38(2):142–9. https://doi.org/10.1002/lsm.20254. (PMID: 16392146).

    Article  PubMed  Google Scholar 

  19. Kroon MW, Wind BS, Meesters AA, et al. Non-ablative 1550 nm fractional laser therapy not effective for erythema dyschromicum perstans and postinflammatory hyperpigmentation: a pilot study. J Dermatol Treat. 2012;23(5):339–44. https://doi.org/10.3109/09546634.2011.565016.

    Article  Google Scholar 

  20. Alharbi MA. 1927 nm thulium laser successfully treats postInflammatory hyperpigmentation in skin of color. Dermatol Res Pract. 2021;2021:5560386. https://doi.org/10.1155/2021/5560386.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Bae YSC, Rettig S, Weiss E, Bernstein L, Geronemus R. Treatment of post-inflammatory hyperpigmentation in patients with darker skin types using a low energy 1,927 nm non-ablative fractional laser: a retrospective photographic review analysis. Lasers Surg Med. 2020;52(1):7–12. https://doi.org/10.1002/lsm.23173.

    Article  PubMed  Google Scholar 

  22. Katz TM, Goldberg LH, Firoz BF, Friedman PM. Fractional photothermolysis for the treatment of postinflammatory hyperpigmentation. Dermatol Surg. 2009;35(11):1844–8. https://doi.org/10.1111/j.1524-4725.2009.01303.x.

    Article  CAS  PubMed  Google Scholar 

  23. Cho SB, Lee SJ, Kang JM, Kim YK, Oh SH. Treatment of refractory arcuate hyperpigmentation using a fractional photothermolysis system. J Dermatol Treat. 2010;21(2):107–8. https://doi.org/10.3109/09546630902936794.

    Article  Google Scholar 

  24. Lee SJ, Chung WS, Lee JD, Kim HS. A patient with cupping-related post-inflammatory hyperpigmentation successfully treated with a 1,927 nm thulium fiber fractional laser. J Cosmet Laser Ther. 2014;16(2):66–8. https://doi.org/10.3109/14764172.2013.854121.

    Article  PubMed  Google Scholar 

  25. Ren R, Zhao H. A case report on the use of 755-nm alexandrite picosecond laser in the treatment of post-inflammatory hyperpigmentation in the nose. J Cosmet Dermatol. 2021. https://doi.org/10.1111/jocd.14332. (Epub 2021 Jul 5).

    Article  PubMed  Google Scholar 

  26. Lee YJ, Shin HJ, Noh TK, Choi KH, Chang SE. Treatment of melasma and post-inflammatory hyperpigmentation by a picosecond 755-nm alexandrite laser in Asian patients. Ann Dermatol. 2017;29(6):779–81. https://doi.org/10.5021/ad.2017.29.6.779.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Ren R, Bao S, Qian W, Zhao H. 755-nm Alexandrite picosecond laser with a diffractive lens array or zoom handpiece for post-inflammatory hyperpigmentation: two case reports with a three-year follow-up. Clin Cosmet Investig Dermatol. 2021;14:1459–64. https://doi.org/10.2147/CCID.S323872.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Lin CH, Tsai YJ, Lin KC, et al. Laser-assisted drug delivery of tranexamic acid by picosecond laser in postinflammatory hyperpigmentation: a split-area double blind randomized prospective study. Photobiomodul Photomed Laser Surg. 2021;39(11):711–5. https://doi.org/10.1089/photob.2021.0086.

    Article  CAS  PubMed  Google Scholar 

  29. Tawfic SO, Abdel Hay R, Salim H, Elmasry MF. Tranexamic acid versus fractional carbon dioxide laser in post-acne hyperpigmentation. Dermatol Ther. 2021;34(6):e15103. https://doi.org/10.1111/dth.15103.

    Article  CAS  PubMed  Google Scholar 

  30. Oram Y, Akkaya AD. Refractory postinflammatory hyperpigmentation treated fractional CO2 laser. J Clin Aesthet Dermatol. 2014;7(3):42–4.

    PubMed  PubMed Central  Google Scholar 

  31. Manuskiatti W, Triwongwaranat D, Varothai S, Eimpunth S, Wanitphakdeedecha R. Efficacy and safety of a carbon-dioxide ablative fractional resurfacing device for treatment of atrophic acne scars in Asians. J Am Acad Dermatol. 2010;63(2):274–83. https://doi.org/10.1016/j.jaad.2009.08.051.

    Article  PubMed  Google Scholar 

  32. Chan NP, Ho SG, Yeung CK, Shek SY, Chan HH. Fractional ablative carbon dioxide laser resurfacing for skin rejuvenation and acne scars in Asians. Lasers Surg Med. 2010;42(9):615–23. https://doi.org/10.1002/lsm.20974.

    Article  PubMed  Google Scholar 

  33. Taylor CR, Anderson RR. Ineffective treatment of refractory melasma and postinflammatory hyperpigmentation by Q-switched ruby laser. J Dermatol Surg Oncol. 1994;20(9):592–7. https://doi.org/10.1111/j.1524-4725.1994.tb00152.x.

    Article  CAS  PubMed  Google Scholar 

  34. Kopera D, Hohenleutner U. Ruby laser treatment of melasma and postinflammatory hyperpigmentation. Dermatol Surg. 1995;21(11):994. https://doi.org/10.1111/j.1524-4725.1995.tb00545.x.

    Article  CAS  PubMed  Google Scholar 

  35. Park KY, Choi SY, Mun SK, Kim BJ, Kim MN. Combined treatment with 578-/511-nm copper bromide laser and light-emitting diodes for post-laser pigmentation: a report of two cases: 578-/511-nm copper bromide laser with LED for PIH. Dermatol Ther. 2014;27(2):121–5. https://doi.org/10.1111/dth.12080.

    Article  PubMed  Google Scholar 

  36. Austin E, Geisler AN, Nguyen J, et al. Visible light. Part I: properties and cutaneous effects of visible light. J Am Acad Dermatol. 2021;84(5):1219–31. https://doi.org/10.1016/j.jaad.2021.02.048.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Taylor SC, Alexis AF, Armstrong AW, Chiesa Fuxench ZC, Lim HW. Misconceptions of photoprotection in skin of color. J Am Acad Dermatol Epub. 2021. https://doi.org/10.1016/j.jaad.2021.12.020.

    Article  Google Scholar 

  38. Agbai ON, Buster K, Sanchez M, et al. Skin cancer and photoprotection in people of color: a review and recommendations for physicians and the public. J Am Acad Dermatol. 2014;70(4):748–62. https://doi.org/10.1016/j.jaad.2013.11.038.

    Article  PubMed  Google Scholar 

  39. Kaye ET, Levin JA, Blank IH, Arndt KA, Anderson RR. Efficiency of opaque photoprotective agents in the visible light range. Arch Dermatol. 1991;127(3):351–5. https://doi.org/10.1001/archderm.1991.01680030071009.

    Article  CAS  PubMed  Google Scholar 

  40. Lim HW, Kohli I, Ruvolo E, Kolbe L, Hamzavi IH. Impact of visible light on skin health: the role of antioxidants and free radical quenchers in skin protection. J Am Acad Dermatol. 2022;86(3):S27-37. https://doi.org/10.1016/j.jaad.2021.12.024.

    Article  CAS  PubMed  Google Scholar 

  41. Lyons AB, Zubair R, Kohli I, et al. Mitigating visible light and long wavelength UVA1-induced effects with topical antioxidants. Photochem Photobiol. 2022;98(2):455–60. https://doi.org/10.1111/php.13525.

    Article  CAS  PubMed  Google Scholar 

  42. Segars K, McCarver V, Miller RA. Dermatologic applications of polypodium leucotomos: a literature review. J Clin Aesthet Dermatol. 2021;14(2):50–60.

    PubMed  PubMed Central  Google Scholar 

  43. Ishack S, Lipner SR. Exogenous ochronosis associated with hydroquinone: a systematic review. Int J Dermatol. 2021. https://doi.org/10.1111/ijd.15878. (Epub 2021 Sep 6).

    Article  PubMed  Google Scholar 

  44. Callender VD, St Surin-Lord S, Davis EC, Maclin M. Postinflammatory hyperpigmentation: etiologic and therapeutic considerations. Am J Clin Dermatol. 2011;12(2):87–99. https://doi.org/10.2165/11536930-000000000-00000.

    Article  PubMed  Google Scholar 

  45. Roggenkamp D, Dlova N, Mann T, et al. Effective reduction of post-inflammatory hyperpigmentation with the tyrosinase inhibitor isobutylamido-thiazolyl-resorcinol (thiamidol). Int J Cosmet Sci. 2021;43(3):292–301. https://doi.org/10.1111/ics.12694.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Desai S, Hartman C, Grimes P, Shah S. Topical stabilized cysteamine as a new treatment for hyperpigmentation disorders: melasma, post-inflammatory hyperpigmentation, and lentigines. J Drugs Dermatol. 2021;20(12):1276–9. https://doi.org/10.36849/jdd.6367.

    Article  PubMed  Google Scholar 

  47. Mathe N, Balogun M, Yoo J. A case report on the use of topical cysteamine 5% cream in the management of refractory postinflammatory hyperpigmentation (PIH) resistant to triple combination cream (hydroquinone, topical corticosteroids, and retinoids). J Cosmet Dermatol. 2021;20(1):204–6. https://doi.org/10.1111/jocd.13755.

    Article  PubMed  Google Scholar 

  48. Chaowattanapanit S, Silpa-Archa N, Kohli I, Lim HW, Hamzavi I. Postinflammatory hyperpigmentation: a comprehensive overview: treatment options and prevention. J Am Acad Dermatol. 2017;77(4):607–21. https://doi.org/10.1016/j.jaad.2017.01.036. (PMID: 28917452).

    Article  PubMed  Google Scholar 

  49. Ho SGY, Yeung CK, Chan NPY, Shek SY, Kono T, Chan HHL. A retrospective analysis of the management of acne post-inflammatory hyperpigmentation using topical treatment, laser treatment, or combination topical and laser treatments in oriental patients. Lasers Surg Med. 2011;43(1):1–7. https://doi.org/10.1002/lsm.21010.

    Article  CAS  PubMed  Google Scholar 

  50. Kim MS, Bang SH, Kim JH, Shin HJ, Choi JH, Chang SE. Tranexamic acid diminishes laser-induced melanogenesis. Ann Dermatol. 2015;27(3):250–6. https://doi.org/10.5021/ad.2015.27.3.250. (Epub 2015 May 29. PMID: 26082580; PMCID: PMC4466276.37).

    Article  PubMed  PubMed Central  Google Scholar 

  51. Lindgren AL, Austin AH, Welsh KM. The use of tranexamic acid to prevent and treat post-inflammatory hyperpigmentation. J Drugs Dermatol. 2021;20(3):344–5. https://doi.org/10.36849/JDD.5622. (PMID: 33683077).

    Article  PubMed  Google Scholar 

  52. Lee YB, Park SM, Kim JW, Yu DS. Combination treatment of low-fluence Q-switched Nd:YAG laser and oral tranexamic acid for post-inflammatory hyperpigmentation due to allergic contact dermatitis to henna hair dye. J Cosmet Laser Ther. 2016;18(2):95–7. https://doi.org/10.3109/14764172.2015.1114634.

    Article  PubMed  Google Scholar 

  53. Kato H, Araki J, Eto H, et al. A prospective randomized controlled study of oral tranexamic acid for preventing postinflammatory hyperpigmentation after Q-Switched ruby laser. Dermatol Surg. 2011;37(5):605–10. https://doi.org/10.1111/j.1524-4725.2011.01957.x.

    Article  CAS  PubMed  Google Scholar 

  54. Rutnin S, Pruettivorawongse D, Thadanipon K, Vachiramon V. A prospective randomized controlled study of oral tranexamic acid for the prevention of postinflammatory hyperpigmentation after Q-switched 532-nm Nd:YAG laser for solar lentigines. Lasers Surg Med. 2019;51(10):850–8. https://doi.org/10.1002/lsm.23135.

    Article  PubMed  Google Scholar 

  55. Sirithanabadeekul P, Srieakpanit R. Intradermal tranexamic acid injections to prevent post-inflammatory hyperpigmentation after solar lentigo removal with a Q-switched 532-nm Nd:YAG laser. J Cosmet Laser Ther. 2018;20(7–8):398–404. https://doi.org/10.1080/14764172.2018.1444770.

    Article  PubMed  Google Scholar 

  56. Burns RL, Prevost-Blank PL, Lawry MA, Lawry TB, Faria DT, Fivenson DP. Glycolic acid peels for postinflammatory hyperpigmentation in black patients: a comparative study. Dermatol Surg. 1997;23(3):171–4. https://doi.org/10.1111/j.1524-4725.1997.tb00014.x. (discussion 175).

    Article  CAS  PubMed  Google Scholar 

  57. Joshi SS, Boone SL, Alam M, et al. Effectiveness, safety, and effect on quality of life of topical salicylic acid peels for treatment of postinflammatory hyperpigmentation in dark skin. Dermatol Surg. 2009;35(4):638–44. https://doi.org/10.1111/j.1524-4725.2009.01103.x.

    Article  CAS  PubMed  Google Scholar 

  58. Lee GY, Kim HJ, Whang KK. The effect of combination treatment of the recalcitrant pigmentary disorders with pigmented laser and chemical peeling. Dermatol Surg. 2002;28(12):1120–3. https://doi.org/10.1046/j.1524-4725.2002.02112.x. (discussion 1123).

    Article  PubMed  Google Scholar 

  59. Park JH, Kim JI, Kim WS. Treatment of persistent facial postinflammatory hyperpigmentation with novel pulse-in-pulse mode intense pulsed light. Dermatol Surg. 2016;42(2):218–24. https://doi.org/10.1097/DSS.0000000000000627.

    Article  CAS  PubMed  Google Scholar 

  60. Li N, Han J, Hu D, Cheng J, Wang H, Wang Y, Yang X, Liu J, Li T, Zhao W. Intense pulsed light is effective in treating postburn hyperpigmentation and telangiectasia in Chinese patients. J Cosmet Laser Ther. 2018;20(7–8):436–41. https://doi.org/10.1080/14764172.2017.1418517. (Epub 2018 Feb 16, PMID: 29452029).

    Article  PubMed  Google Scholar 

  61. Goh CL, Abad-Casintahan F, Chow SKW, et al. Evaluating acne-related post-inflammatory hyperpigmentation is a challenge even amongst experts. J Dermatol. 2014;41(12):1106–8. https://doi.org/10.1111/1346-8138.12667.

    Article  PubMed  Google Scholar 

  62. Savory SA, Agim NG, Mao R, et al. Reliability assessment and validation of the Postacne Hyperpigmentation Index (PAHPI), a new instrument to measure postinflammatory hyperpigmentation from acne vulgaris. J Am Acad Dermatol. 2014;70(1):108–14. https://doi.org/10.1016/j.jaad.2013.09.017.

    Article  PubMed  Google Scholar 

  63. Taylor SC, Arsonnaud S, Czernielewski J, Hyperpigmentation Scale Study Group. The Taylor Hyperpigmentation Scale: a new visual assessment tool for the evaluation of skin color and pigmentation. Cutis. 2005;76(4):270–4.

    PubMed  Google Scholar 

  64. Kang BY, Ibrahim SA, Shokeen D, et al. Postinflammatory hyperpigmentation: protocol for development of a core outcome set for clinical trials. Arch Dermatol Res. 2021. https://doi.org/10.1007/s00403-021-02239-6. (Epub 2021 May 21).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Medstar Georgetown University Hospital/Washington Hospital Center, Washington, DC, USA

    Madeleine Sowash

  2. Washington Institute of Dermatologic Laser Surgery, Washington, DC, USA

    Tina Alster

Authors
  1. Madeleine Sowash
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tina Alster
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Madeleine Sowash.

Ethics declarations

Funding

No sources of funding were received for the preparation of this article.

Conflicts of interest/competing interests

Madeleine Sowash and Tina Alster have no conflicts of interest that are directly relevant to the content of this article.

Ethics approval

Not applicable.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Availability of data and material

Not applicable.

Code availability

Not applicable.

Authors’ contributions

MS drafted the manuscript and TA edited the manuscript.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sowash, M., Alster, T. Review of Laser Treatments for Post-Inflammatory Hyperpigmentation in Skin of Color. Am J Clin Dermatol 24, 381–396 (2023). https://doi.org/10.1007/s40257-023-00759-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40257-023-00759-7

Search

Navigation